SCHEMBL8517857

SCHEMBL8517857

CC(COCCCCCC(=O)c1ccc(F)cc1)N1C(=O)CC1[S+]([O-])Cc1ccc(C(=O)O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.35
MEN1 O00255 1/20 0.35
CHRM2 P08172 1/20 0.35
ADRA2A P08913 1/20 0.35
DRD1 P21728 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
KMT2A Q03164 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
DRD2 P14416 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33
HTR7 P34969 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
DRD4 P21917 1/20 0.33
HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591797 0.94 DRD2 (0.38) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8378215 0.92 CXCR3 (0.35) HRH3DRD2
SCHEMBL8517128 0.90 MAPT (0.37) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8378710 0.90 DRD3 (0.38) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8374000 0.88 MEN1 (0.32) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8517073 0.86 MCHR1 (0.37) HTR1ADRD3DRD2HTR7HTR2A
SCHEMBL8518266 0.84 DRD2 (0.41) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8378712 0.83 DRD3 (0.39) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8378225 0.83 MEN1 (0.35) HTR1AMEN1CHRM2ADRA2ADRD1
SCHEMBL8374698 0.82 ALDH1A1 (0.36) MEN1CHRM2KMT2AKCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900199-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1999-03-10 EP claimed
WO-1997041099-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-11-06 WO claimed
EP-0900199-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1999-03-10 EP disclosed
WO-1997041099-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-11-06 WO disclosed